| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.90▼ | 8.88▼ | 8.88▼ | 8.99▼ | 8.99▼ |
| MA10 | 8.94▼ | 8.97▼ | 8.97▼ | 8.99▼ | 9.05▼ |
| MA20 | 9.04▼ | 9.04▼ | 9.01▼ | 9.00▼ | 8.88▼ |
| MA50 | 9.06▼ | 9.06▼ | 9.04▼ | 9.06▼ | 8.86▼ |
| MA100 | 9.05▼ | 9.05▼ | 9.07▼ | 8.86▼ | 10.24▼ |
| MA200 | 9.14▼ | 9.06▼ | 9.06▼ | 8.58▲ | 17.80▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.035▼ | -0.033▼ | -0.009▼ | 0.008▲ |
| RSI | 43.031▼ | 42.048▼ | 42.973▼ | 41.859▼ | 48.809▼ |
| STOCH | 33.223 | 20.484 | 19.892▼ | 24.306 | 37.823 |
| WILL %R | -90.323▼ | -91.089▼ | -91.089▼ | -94.323▼ | -67.925 |
| CCI | -103.021▼ | -107.961▼ | -109.478▼ | -156.784▼ | -18.146 |
|
Friday, October 02, 2026 01:30 AM
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, ...
|
|
Tuesday, June 10, 2025 01:30 PM
WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies ...
|
|
Friday, June 06, 2025 07:00 PM
Xilio Therapeutics, Inc. (NASDAQ:XLO) announced promising updated Phase 2 results for its investigational therapy vilastobart, combined with atezolizumab, in heavily pre-treated patients with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/10/26 | 8.995 | 9.09 | 8.775 | 8.82 | 18,243 |
| 07/10/26 | 9.00 | 9.01 | 9.00 | 9.01 | 885 |
| 06/10/26 | 9.10 | 9.32 | 8.81 | 9.00 | 6,197 |
| 05/10/26 | 9.07 | 9.49 | 9.07 | 9.11 | 7,157 |
| 02/10/26 | 8.89 | 9.075 | 8.89 | 9.01 | 7,400 |
| 01/10/26 | 8.97 | 9.12 | 8.79 | 8.91 | 12,885 |
| 30/09/26 | 9.19 | 9.25 | 9.05 | 9.05 | 5,362 |
| 29/09/26 | 9.5677 | 9.5677 | 8.9378 | 8.9378 | 3,114 |
| 28/09/26 | 9.21 | 9.22 | 8.96 | 9.05 | 11,128 |
| 25/09/26 | 9.00 | 9.21 | 8.93 | 9.04 | 3,418 |
|
|
||||
|
|
||||
|
|